SCHEMBL12818506

SCHEMBL12818506

Cc1nc2ccc(S(=O)(=O)N3CCOc4ccc(-c5ccncc5)cc43)cc2o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.42
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ PIK3CD O00329 1/20 0.39
▸ PIK3CA P42336 1/20 0.39
▸ PIK3CB P42338 1/20 0.39
▸ PIK3CG P48736 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ PDE3B Q13370 4/20 0.38
▸ PDE3A Q14432 4/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ CPT1A P50416 4/20 0.37
▸ CPT1B Q92523 3/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CPT2 P23786 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ PKLR P30613 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818304 0.88 PKM (0.43) CYP2C9MEN1KMT2AMAPTPDE3B
SCHEMBL12818912 0.87 PIK3CA (0.42) CYP2C9MEN1KMT2APIK3CDPIK3CA
SCHEMBL12818721 0.85 CYP2C9 (0.40) CYP2C9MEN1KMT2APIK3CDPIK3CA
SCHEMBL12818812 0.85 CYP2C9 (0.43) CYP2C9MEN1KMT2APIK3CAMAPT
SCHEMBL12818485 0.84 PDE3B (0.39) CYP2C9MEN1KMT2APIK3CAMAPT
SCHEMBL12818990 0.82 CYP2C9 (0.38) CYP2C9MEN1KMT2AMAPTPDE3B
SCHEMBL12817618 0.78 MEN1 (0.41) CYP2C9MEN1KMT2AMAPTPDE3B
SCHEMBL12818134 0.78 CYP2C9 (0.40) CYP2C9MEN1KMT2APIK3CDPIK3CA
SCHEMBL12818629 0.78 HTR6 (0.41) CYP2C9MEN1KMT2APIK3CDPIK3CA
SCHEMBL12817769 0.78 CYP2C9 (0.38) CYP2C9MEN1KMT2AMAPTPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback